Followers | 1106 |
Posts | 279775 |
Boards Moderated | 10 |
Alias Born | 03/18/2011 |
Tuesday, May 01, 2012 8:17:18 AM
~ $CRL ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=CRL&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=CRL&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=CRL
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CRL#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CRL+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CRL
Finviz: http://finviz.com/quote.ashx?t=CRL
~ BusyStock: http://busystock.com/i.php?s=CRL&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CRL >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
My stuff http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64797507
Never, invest with money you need to survive. Diversify, patience, set tight stops. $20 or less in commission fees is almost always cheaper than a 5-40%+ drop in share value.
Recent CRL News
- Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP • Business Wire • 05/02/2024 12:00:00 PM
- Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally • Business Wire • 04/22/2024 12:00:00 PM
- Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing • Business Wire • 04/16/2024 12:00:00 PM
- Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call • Business Wire • 04/12/2024 12:00:00 PM
- Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology • Business Wire • 04/11/2024 12:00:00 PM
- Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics • Business Wire • 04/09/2024 12:00:00 PM
- Charles River to Perform Plasmid Production for Ship of Theseus • Business Wire • 04/04/2024 12:00:00 PM
- Charles River to Perform Plasmid Production for Ship of Theseus • Business Wire • 04/04/2024 12:00:00 PM
- Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 • Business Wire • 04/01/2024 12:00:00 PM
- Charles River Laboratories Publishes 2023 Corporate Citizenship Report • Business Wire • 03/27/2024 12:00:00 PM
- Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine • Business Wire • 03/21/2024 12:00:00 PM
- Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration • Business Wire • 03/14/2024 12:00:00 PM
- Charles River Laboratories to Present at Barclays Global Healthcare Conference • Business Wire • 03/12/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:42:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 07:34:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:54:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:09:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 05:47:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:37:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 08:14:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 05:42:07 PM
- Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use • PR Newswire (US) • 02/29/2024 07:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:57:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 04:09:04 PM
- Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing • Business Wire • 02/21/2024 01:00:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM